Tofacitinib relieves symptoms of stimulator of interferon genes (STING)-associated vasculopathy with onset in infancy caused by 2 de novo variants in TMEM173

Affiliations

• ¹ Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea.
• ² Cell Logistics Research Center and School of Life Sciences, Gwangju Institute of Science and Technology, Gwangju, Korea.
• ³ Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea.
• ⁴ Department of Biological Sciences, Korea Advanced Institute of Science and Technology, Daejeon, Korea.
• ⁵ Department of Dermatology, Seoul National University College of Medicine, Seoul, Korea.
• ⁶ School of Liberal Arts and Sciences, Gwangju Institute of Science and Technology, Gwangju, Korea.
• ⁷ Department of Pediatrics, Kyungpook National University School of Medicine, Daegu, Korea.
• ⁸ Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea; Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea. Electronic address: murimchoi@snu.ac.kr.
• ⁹ Cell Logistics Research Center and School of Life Sciences, Gwangju Institute of Science and Technology, Gwangju, Korea. Electronic address: sgpark@gist.ac.kr.
• ¹⁰ Department of Pediatrics, Seoul National University College of Medicine, Seoul, Korea. Electronic address: chaeped1@snu.ac.kr.